Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244452
Status:
COMPLETED
Last Update Posted:
2008-03-31
First Post:
2005-10-25
Brief Title:
A Multinational Randomized Double-Blind Placebo-Controlled Parallel Group Study to Investigate the Efficacy Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
Sponsor:
Organization:
Solvay Pharmaceuticals